Scale -


  • Revenue is 1679 Rs Cr; Annual Growth is 21 %; Continuous Growth over 3 years; 5 Year CAGR is 10 %
  • Ebitda is 476 Rs Cr; Annual Growth is 18 %; Continuous Growth over 3 years
  • PBT is 105 Rs Cr; Annual Growth is 24 %; Continuous Growth over 3 years; in Top Quartile
  • PAT is 274 Rs Cr; Annual Growth is 28 %; Continuous Growth over 3 years; in Top Quartile
  • Quarterly Revenue is 476 Rs Cr; Continuous Growth over 3 Quarters

Profitability -


  • PAT Margin is 16.28 %; Continuous Growth over 3 years; in Top Quartile
  • Quarterly Profit margin is 19 %; Continuous Growth over 3 Quarters; in Top Quartile
  • Quarterly Ebitda Margin is 27 %; in Top Quartile

Return -


  • ROCE is 18.1 %; in Top Quartile; 5 Year CAGR is -19 %
  • ROA is 9.17 %; in Top Quartile
  • ROE is 12.84 %; Annual Decline is -33 %; 5 Year CAGR is -26 %
  • Asset Turnover is 68 %; Continuous Decline over 3 years

Efficiency -


  • Operating cash flow is 329 Rs Cr; Annual Growth is 72 %
  • Current Ratio is 2.06; Continuous Growth over 3 years
  • Quick Ratio is 2.05; Continuous Growth over 3 years
  • Inventory Turnover Ratio is 617; in Top Quartile

Solvancy -


  • Debt/Equity is 0.11; Annual Decline is -81 %; Continuous Decline over 3 years; 5 Year CAGR is -49 %
  • Long term Debt is 18.96 Rs Cr; Annual Decline is -95 %; Continuous Decline over 3 years; 5 Year CAGR is -61 %
  • Total Debt is 228 Rs Cr; Annual Decline is -63 %; Continuous Decline over 3 years; 5 Year CAGR is -26 %
  • Contingent Liabilities is 364 Rs Cr; Annual Decline is -48 %; Continuous Decline over 3 years; in Top Quartile

Quality -


  • Operating cashflow/ebitda is 69 %; Annual Growth is 46 %
  • Operating cashflow/PAT is 120 %; Annual Growth is 34 %
  • Current Tax/PAT is 30 %; Continuous Decline over 3 years
  • Other Expenses/Total Expenses is 26 %; in Bottom Quartile
  • Change in Inventories/Total Expenses is 0 %; 5 Year CAGR is -50 %; Annual Growth is 285 %; in Top Quartile
  • Exceptional Items/PBT is 0 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem


Sector
Major Subsidiaries/Associates
Key Clients

Products


Products
Product details

Operations


Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
Park Hospitals Strengthens Its Healthcare Presence Across North India
Park Hospitals Dr. Ajit Gupta Honoured with Lifetime Achievement Award for Contributions to Healthcare
Park Medi World Shares Fall After Major Hospital Expansion Plan; Healthcare Stock's 28-Year Agreement In Focus
Park Medi World Limited Estimates – NSE:PARKHOSPS
Park Medi World (PARKHOSPS.NS) Eases 1.19% to ?215.1, Holding Mid-Range Between ?204.34 and ?225.85
Park Medi World Ltd Updates on Income Tax Department Verification Process
Park Medi World Ltd: ???? ???? ????? ?? ???? ??? ???? ????? ?? ???? ????
Stock To Buy For Long-Term: Nuvama Calls Park Medi World A Buy For Rs 280 Target; 39% Upside Seen
Park Hospital begins construction of 550-bed multi-speciality hospital in Prayagraj
Park Medi World (PARKHOSPS.NS) Trades at ?235.95, Right at the Midpoint of Its Range
Park Medi World Expands Uttar Pradesh Presence with 550 Bed Prayagraj Hospital Project
Park Medi World PARKHOSPS Income Tax Verification Disclosure
15% Off a 42% Profit Grower: Park Medi World's Sell-off Could Be 2026's Best Hospital-Stock Opportunity
Park Medi World Ltd Wins PPP Mandate to Develop 550-Bed Super-Speciality Hospital in Prayagraj with Rs. 200 Cr Investment
Park Medi World shares: Hospital stock dips 15% in a month — Will the stock rebound? Experts show road map to investors
Explained
PARK MEDI WORLD Share Price Down 6.56%: Key Data
Park Medi World Shares Fall 15%: Rebound Levels and Targets
Park Medi World vs Nifty 50: 6M Return +27.34% vs -6.49%
Park Medi World: Cancer Drug Price Cap Will Barely Hurt Its Business
Is Park Medi World the Best Stock in Its Sector? A Look at the Numbers